4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000039
President and CEO sold 7,818 shares at $19.78 ($154,640)
From the SEC's structured data for this filing
Trades in this filing
Watts Ryan J. · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-01-09 | Sale : show line 1 in the form | −7,818 | $19.78 | $154,640 | 2,268,363 | I |
| Open-market sales · 7,818 sh · avg $19.78 · $154,640 | ||||||
Loading xslF345X05/wk-form4_1705012085.xml…